Cost utility analysis of deferasiroxversus deferoxamine for patients requiring iron chelation therapy in the United Kingdom

被引：0
作者：
Karnon, J.
Akehurst, R. L.
Jewitt, K.
Ossa, D.
机构：
[1] Univ Sheffield, Sheffield, S Yorkshire, England
[2] Novartis Plc, Camberley, England
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2007年 / 92卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0598
引用
收藏
页码：222 / 223
页数：2
相关论文
共 50 条
  • [31] Iron chelation therapy with deferasirox (Exjade®, ICL670) or deferoxamine is effective in reducing iron overload in patients with advanced fibrosis and cirrhosis.
    Angelucci, E
    Turlin, B
    Canatan, D
    Mangiagli, A
    De Sanctis, V
    Meddeb, B
    Rose, C
    Soulieres, D
    Cunningham, M
    Gattermann, N
    Ressayre-Djaffer, C
    Rabault, B
    Ford, J
    BLOOD, 2005, 106 (11) : 757A - 758A
  • [32] Estimating the total cost of infused iron chelation therapy.
    Desrosiers, MP
    Payne, KA
    Baladi, JF
    BLOOD, 2005, 106 (11) : 482B - 482B
  • [33] A COST-UTILITY ANALYSIS OF FERRIC DERISOMALTOSE VERSUS FERRIC CARBOXYMALTOSE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE IN THE UNITED KINGDOM
    Iqbal, T. H.
    Kennedy, N. A.
    Sorensen, J.
    Nottmeier, M.
    Pollock, R. F.
    VALUE IN HEALTH, 2022, 25 (12) : S133 - S133
  • [34] IRON CHELATION THERAPY FOR PATIENTS WITH MYELODYSPLASTIC SYNDROME
    Yeh, Su-Peng
    Yang, Yang-Sheng
    Yao, Chao-Yuan
    Peng, Ching-Tien
    HEMOGLOBIN, 2009, 33 (05) : 339 - 345
  • [35] Comparison between Deferoxamine and Combined Therapy with Deferoxamine and Deferiprone in Iron Overloaded Thalassemia Patients
    Tamaddoni, A.
    Ramezani, M. S.
    IRANIAN RED CRESCENT MEDICAL JOURNAL, 2010, 12 (06) : 655 - 659
  • [36] SUCCESSFUL CHELATION THERAPY WITH THE COMBINATION OF DEFERASIROX AND DEFERIPRONE (3 PATIENTS) AND DEFEROXAMINE AND DEFERASIROX (2 PATIENTS).
    de la Iglesia, Si
    Herrera, A.
    Arrizabalaga, B.
    Nunez, G.
    Orero, M.
    Amarika, I.
    Villegas, A.
    HAEMATOLOGICA, 2013, 98 : 708 - 708
  • [37] COMBINATION OF DEFERASIROX AND DEFEROXAMINE A SUCCESSFUL CHELATION THERAPY IN B-THALASSEMIA MAJOR PATIENTS
    Petropoulou, F.
    Ventiadi, K.
    Leveta, G.
    HAEMATOLOGICA, 2017, 102 : 868 - 868
  • [38] ULTRAFILTRATION STUDIES INVITRO OF SERUM ALUMINUM IN DIALYSIS PATIENTS AFTER DEFEROXAMINE CHELATION THERAPY
    LEUNG, FY
    HODSMAN, AB
    MUIRHEAD, N
    HENDERSON, AR
    CLINICAL CHEMISTRY, 1985, 31 (01) : 20 - 23
  • [39] Urinary iron excretion in young thalassemic patients receivina combined chelation treatment with deferoxamine and deferiprone
    Christoforidis, Athanasios
    Zevgaridou, Eleni
    Tsatra, Ioanna
    Perifanis, Vassilios
    Vlachaki, Efthimia
    Papassotiriou, Ioannis
    Apostolakou, Filia
    Athanassiou-Metaxa, Miranda
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2007, 29 (09) : 598 - 601
  • [40] Dose response of deferoxamine, deferiprone, and ICL670 chelation therapy in a gerbil model of iron overload
    Wood, JC
    Otto-Duessel, M
    Aguilar, M
    Nick, H
    Coates, TD
    Rex, M
    BLOOD, 2004, 104 (11) : 985A - 985A
12345